|
Market Closed -
Nasdaq
04:00:00 2026-09-09 pm EDT
|
5-day change | 1st Jan Change | ||
| 521.12 USD | -1.47% |
|
-6.40% | +14.95% |
| Market Cap | 132B 114B 107B 97.51B 182B 12,569B 183B 1,268B 490B 6,403B 496B 485B 20,285B | P/E 2026 * |
53.6x | P/E 2027 * | 28.2x |
|---|---|---|---|---|---|
| Enterprise Value | 127B 109B 103B 93.6B 175B 12,064B 176B 1,217B 471B 6,146B 476B 466B 19,471B | EV / Sales 2026 * |
9.57x | EV / Sales 2027 * | 8.54x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VRTX | Delayed | |
CBOE
| VRTX | Real-time | |
|
Tradegate
| VX1 | Real-time | |
|
Mexican S.E.
| VRTX * | End-of-day quote | |
|
Xetra
| VX1 | Delayed | |
|
Deutsche Boerse AG
| VX1 | Delayed | |
|
Boerse Muenchen
| VX1 | Real-time | |
|
London S.E.
| 0QZU | Delayed | |
|
Wiener Boerse
| VRTX | End-of-day quote | |
|
Borsa Italiana
| 1VRTX | End-of-day quote | |
|
Börse Stuttgart
| VX1 | Delayed | |
|
CBOE
| 0QZU | Real-time | |
|
CBOE
| Real-time |
Last Transcript : Vertex Pharmaceuticals Incorporated
| 1 day | -1.47% | ||
| 1 week | -6.40% | ||
| Current month | -4.30% | ||
| 1 month | +5.05% | ||
| 3 months | +16.90% | ||
| 6 months | +13.07% | ||
| Current year | +14.95% |
| 1 week | 520.08 |  | 556.99 |
| 1 month | 502.29 | | 560.25 |
| Current year | 412.27 | | 560.25 |
| 1 year | 374.17 | | 560.25 |
| 3 years | 341.85 | | 560.25 |
| 5 years | 176.36 | | 560.25 |
| 10 years | 71.46 | | 560.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2020-03-31 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 2019-04-09 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 1997-12-31 |
Jeffrey Leiden
CHM | Chairman | 70 | 2012-04-30 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 2015-06-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/28/26 | Free | Controller/Auditor | 5,000 | 0.0020% | ||
| 8/27/26 | Don | Director | -6,000 | 0.0024% | ||
| 7/21/26 | Free | General Counsel | 8,251 | 0.0033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.47% | -6.40% | +31.44% | +51.91% | 134B | |
| +0.03% | -3.09% | +49.77% | +91.69% | 1,002B | |
| -0.76% | -2.95% | +50.93% | +66.34% | 649B | |
| +0.86% | -4.13% | +19.24% | +68.37% | 440B | |
| -0.80% | -0.43% | +28.92% | +35.45% | 346B | |
| -0.13% | -14.97% | +9.41% | +26.71% | 263B | |
| -1.90% | -2.72% | -2.72% | +7.41% | 250B | |
| -0.48% | -11.65% | +39.75% | +50.82% | 213B | |
| -1.06% | -4.23% | -14.70% | -57.36% | 201B | |
| -0.68% | -2.65% | +25.82% | +91.64% | 182B | |
| Average | -0.66% | -4.62% | +23.79% | +43.30% | 367.77B | |
| Weighted average by Cap. | -0.46% | -3.97% | +31.96% | +56.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.25B 11.4B 10.74B 9.78B 18.3B 1,261B 18.38B 127B 49.18B 642B 49.76B 48.67B 2,035B | 14.5B 12.47B 11.75B 10.7B 20.02B 1,379B 20.1B 139B 53.8B 703B 54.44B 53.25B 2,226B |
| Net income | 2.53B 2.18B 2.05B 1.87B 3.5B 241B 3.52B 24.34B 9.41B 123B 9.52B 9.31B 389B | 4.83B 4.16B 3.91B 3.57B 6.67B 460B 6.7B 46.39B 17.93B 234B 18.14B 17.75B 742B |
| Net Debt | -5.3B -4.56B -4.3B -3.91B -7.32B -504B -7.35B -50.91B -19.68B -257B -19.91B -19.47B -814B | -8.25B -7.1B -6.69B -6.09B -11.4B -785B -11.44B -79.24B -30.63B -400B -30.99B -30.31B -1,267B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | $521.12 | -1.47% | 958,480 |
| 26-09-08 | $528.90 | -3.15% | 1,121,470 |
| 26-09-04 | $546.12 | -2.12% | 803,524 |
| 26-09-03 | $557.96 | +0.22% | 800,963 |
| 26-09-02 | $556.75 | +1.66% | 1,734,757 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions
